Responses
Oral Presentations
FRIDAY, 14 JUNE 2019
Osteoarthritis: Research in motion
SSc and Myositis – novel therapeutic options
OP0245 PRESERVATION OF LUNG FUNCTION OBSERVED IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL OF TOCILIZUMAB FOR THE TREATMENT OF EARLY SSC
Compose a Response to This Article
Other responses
No responses have been published for this article.